232 related articles for article (PubMed ID: 19909990)
1. Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury.
Sharma AK; Laubach VE; Ramos SI; Zhao Y; Stukenborg G; Linden J; Kron IL; Yang Z
J Thorac Cardiovasc Surg; 2010 Feb; 139(2):474-82. PubMed ID: 19909990
[TBL] [Abstract][Full Text] [Related]
2. Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation.
Sharma AK; Linden J; Kron IL; Laubach VE
Respir Res; 2009 Jun; 10(1):58. PubMed ID: 19558673
[TBL] [Abstract][Full Text] [Related]
3. Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.
Gazoni LM; Walters DM; Unger EB; Linden J; Kron IL; Laubach VE
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):440-6. PubMed ID: 20398911
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury.
Yang Z; Sharma AK; Linden J; Kron IL; Laubach VE
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):695-702; discussion 702. PubMed ID: 19258091
[TBL] [Abstract][Full Text] [Related]
5. Tissue-derived proinflammatory effect of adenosine A2B receptor in lung ischemia-reperfusion injury.
Anvari F; Sharma AK; Fernandez LG; Hranjec T; Ravid K; Kron IL; Laubach VE
J Thorac Cardiovasc Surg; 2010 Oct; 140(4):871-7. PubMed ID: 20659747
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A1 receptor activation attenuates lung ischemia-reperfusion injury.
Fernandez LG; Sharma AK; LaPar DJ; Kron IL; Laubach VE
J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1654-9. PubMed ID: 23398646
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury.
Mulloy DP; Sharma AK; Fernandez LG; Zhao Y; Lau CL; Kron IL; Laubach VE
Ann Thorac Surg; 2013 May; 95(5):1762-7. PubMed ID: 23541429
[TBL] [Abstract][Full Text] [Related]
8. Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion.
Gazoni LM; Laubach VE; Mulloy DP; Bellizzi A; Unger EB; Linden J; Ellman PI; Lisle TC; Kron IL
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):156-65. PubMed ID: 18179933
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A(2A) receptor activation.
Lisle TC; Gazoni LM; Fernandez LG; Sharma AK; Bellizzi AM; Shifflett GD; Laubach VE; Kron IL
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1280-7; discussion 1287-8. PubMed ID: 19026816
[TBL] [Abstract][Full Text] [Related]
10. Beta-chemokine function in experimental lung ischemia-reperfusion injury.
Krishnadasan B; Farivar AS; Naidu BV; Woolley SM; Byrne K; Fraga CH; Mulligan MS
Ann Thorac Surg; 2004 Mar; 77(3):1056-62. PubMed ID: 14992926
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model.
LaPar DJ; Laubach VE; Emaminia A; Crosby IK; Hajzus VA; Sharma AK; Sumner HM; Webb DV; Lau CL; Kron IL
J Thorac Cardiovasc Surg; 2011 Oct; 142(4):887-94. PubMed ID: 21762933
[TBL] [Abstract][Full Text] [Related]
12. Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury.
Sharma AK; LaPar DJ; Zhao Y; Li L; Lau CL; Kron IL; Iwakura Y; Okusa MD; Laubach VE
Am J Respir Crit Care Med; 2011 Jun; 183(11):1539-49. PubMed ID: 21317314
[TBL] [Abstract][Full Text] [Related]
13. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition.
Sevigny CP; Li L; Awad AS; Huang L; McDuffie M; Linden J; Lobo PI; Okusa MD
J Immunol; 2007 Apr; 178(7):4240-9. PubMed ID: 17371980
[TBL] [Abstract][Full Text] [Related]
14. The role of proinflammatory cytokines in lung ischemia-reperfusion injury.
Krishnadasan B; Naidu BV; Byrne K; Fraga C; Verrier ED; Mulligan MS
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):261-72. PubMed ID: 12579094
[TBL] [Abstract][Full Text] [Related]
15. Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury.
Naidu BV; Woolley SM; Farivar AS; Thomas R; Fraga CH; Goss CH; Mulligan MS
J Thorac Cardiovasc Surg; 2004 May; 127(5):1502-8. PubMed ID: 15116014
[TBL] [Abstract][Full Text] [Related]
16. NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.
Yang Z; Sharma AK; Marshall M; Kron IL; Laubach VE
Am J Respir Cell Mol Biol; 2009 Mar; 40(3):375-81. PubMed ID: 18787174
[TBL] [Abstract][Full Text] [Related]
17. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice.
Yoshidome H; Lentsch AB; Cheadle WG; Miller FN; Edwards MJ
J Surg Res; 1999 Jan; 81(1):33-7. PubMed ID: 9889054
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and Bax expression and activation of extracellular signal-regulated kinases.
Rivo J; Zeira E; Galun E; Einav S; Linden J; Matot I
Shock; 2007 Mar; 27(3):266-73. PubMed ID: 17304107
[TBL] [Abstract][Full Text] [Related]
19. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury.
Day YJ; Li Y; Rieger JM; Ramos SI; Okusa MD; Linden J
J Immunol; 2005 Apr; 174(8):5040-6. PubMed ID: 15814735
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 exacerbates pulmonary injury after hepatic ischemia/reperfusion in mice.
Takeuchi D; Yoshidome H; Kurosawa H; Kimura F; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Miyazaki M
J Surg Res; 2010 Jan; 158(1):87-93. PubMed ID: 19394645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
